Searched for
DR KRISHNA ELLA
Bharat Biotech founder bats for incentives, tax breaks for patented products, innovationSpeaking at the 72nd IPC in Nagpur earlier in the day, Drugs Controller General of India Dr V G Somani had said the Centre was all set to i...- Bharat Biotech's Covid-19 nasal vaccine phase III trials completedIn an exclusive interview with ANI, Dr Ella said, "We just completed a clinical trial, a data analysis is going on. Next month, we will sub...
- Budget outlay in health sector, vaccine self-reliance has helped biotech industry: Bharat Biotech chairmanDr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Wednesday welcomed the Union Budget 2022 and said that during COVID-19...
- Privileged to be on illustrious list: SII's Poonawalla after being awarded Padma BhushanSerum Institute of India managing director Dr Cyrus S Poonawalla, who was awarded the Padma Bhushan on Tuesday, said it was a great privile...
- Neglected infectious diseases may be tomorrow's pandemic: Bharat Biotech chief Dr Krishna EllaBharat Biotech's Covaxin is credited to be India's first indigenous COVID-19 vaccine to be approved and administered to a sizeable populati...
- Bharat Biotech proud of contribution to historic landmark: Dr Krishna Ella on COVID vaccination coverage crossing 100 cr markTerming the achievement as a "true success story of Atmanirbharta", he said that it was a unified effort of the government, vaccine manufac...
- Bharat Biotech's Karnataka facility will have capacity to make 4-5 crore doses of Covaxin a month by Aug-end: MinisterKarnataka has so far conducted 1.12 crore inoculations of coronavirus vaccines in the state comprising first and second doses whereas it ha...
- 65% of vaccines manufactured in Hyderabad, says Bharat Biotech's Krishna EllaKrishna Ella, whose firm developed India's first indigenous vaccine for Covid-19, said 'pandemic vaccines and everything in future will com...
- Bharat Biotech achieved a milestone in indigenous vaccinology: Karnataka MinisterI humbly appeal to everyone, not as a Health Minister but as a fellow medical professional, to refrain from unwarranted criticism which dis...
- Now, Covaxin to be tested on toddlers as young as 2 yearsCovaxin, being developed by Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, was...
- Bharat Biotech claims its Covid 19 vaccine Covaxin will work against UK strainHyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant strain of novel coronavirus found in the UK ...
- A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of CovaxinThe approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...
- Bharat Biotech: Hyderabad company among frontrunners for a Covid vaccineBharat Biotech has got nod from the DCGI to begin human trials of the first indigenous Covid-19 vaccine.
- Bharat Biotech’s Covid vaccine gets DCGI nod for clinical trialsThe SARS-CoV-2 strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its...
- Buy Granules India, target Rs 116: Manas JaiswalBuy Granules India Ltd. at a price target of Rs 116.0 and a stop loss at Rs 107.5 from the entry point.
- Buy Granules India, target Rs 140: Chandan TapariaBuy Granules India Ltd. at a price target of Rs 140.0 and a stop loss at Rs 128 from entry point.
- Bharat Biotech gets breakthrough in developing Zika vaccineBharat Biotech’s chief managing director Dr Krishna Ella said his company has ‘an early mover advantage’ in developing the Zika vaccine.
- ICICI Ventures, IFC may exit Bharat Biotech; transaction may value company at 1000 croreInvestment banker Avendus has been mandated by ICICI Ventures to find suitors and the initial process has begun, sources in the know said.
- Foot and Mouth disease cause 20,000 crore revenue loss in IndiaIndia annually suffers a staggering revenue loss of about Rs 20,000 crore due to Foot and Mouth Disease that afflicts the bovine population...
- Asia gets its first Bio Safety Level-4 facilityBiovet has launched Asia's first Bio Safety Level-4 (BSL-4) manufacturing facility, specifically designed to enable product development and...
Load More
